
Ackerman and Bunick review 52-week AMETHYST data for litifilimab in refractory cutaneous lupus and make the case for dermatology-led CLE care.
This Month in Review summary includes a list of some of the most notable or impactful news in the dermatology field from May 2025.
Every month, the HCPLive editorial team publishes a new iteration of our Month in Review series, during which a summary provides several highlights of the most notable news coverage from the month in each medical subfield. Here, the team spotlights some of the most significant stories in the field of






